Standout Papers

Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma 1989 2026 2001 2013 1.7k
  1. Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma (1990)
    Charles G. Moertel, Thomas R. Fleming et al. New England Journal of Medicine
  2. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. (1989)
    Michael A. Poon, M. J. OʼConnell et al. Journal of Clinical Oncology
  3. Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. (1989)
    John A. Laurie, C G Moertel et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 104 standout
Sub-graph 1 of 15

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Global cancer statistics, 2012
2015 Standout
1 intermediate paper

Works of John A. Laurie being referenced

Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.
1995

Author Peers

Author Last Decade Papers Cites
John A. Laurie 3516 1361 1117 30 4.6k
Jean François Seitz 2771 957 1019 37 3.7k
Heather‐Jane Au 2818 980 1135 29 3.8k
Guido Francini 3985 1113 1241 113 5.2k
J A Mailliard 4494 1071 1817 59 6.6k
J. S. Macdonald 2757 652 894 68 3.8k
Harry S. Wieand 6126 1407 2034 53 7.9k
Isabelle Tabah-Fisch 3614 976 1011 23 4.5k
C. Topham 5627 1288 1541 37 6.4k
H. Samuel Wieand 3142 1214 811 53 4.9k
Philip R. Clingan 4616 1126 1408 45 5.5k

All Works

Loading papers...

Rankless by CCL
2026